Moreover, the pharmacological inhibition of glycolysis has emerged as a novel strategy for treating cancer since high glycolytic activity is considered as a metabolic hallmark of cancer, PFKFB3 has been also considered as a potential target in cancer treatment [20]. The gene discussed is PFKFB3; the disease is cancer.